Avail Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Avail Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	+455	New	+$218K	0.18%	168

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Avail Investment Partners's TMO Position: Q2 2026 in Review

Avail Investment Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 455 shares worth $228K. The stake represents 0.18% of the portfolio and ranks #168 among its holdings.

2,605 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Avail Investment Partners held 455 shares of Thermo Fisher Scientific worth $228K as of Q2 2026.
Thermo Fisher Scientific was a new Avail Investment Partners position in Q2 2026.
Thermo Fisher Scientific made up 0.18% of Avail Investment Partners's portfolio in Q2 2026, its #168 holding.
2,605 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Avail Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.